Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q80510495)
Watch
English
Tubulin-targeting agents
scientific article published on 01 January 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Tubulin-targeting agents
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
author name string
William N Hait
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
Eric Rubin
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
Susan Goodin
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
publication date
1 January 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
published in
Cancer chemotherapy and biological response modifiers
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
volume
21
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
page(s)
41-67
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
cites work
Tubulin structure: insights into microtubule properties and functions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microtubule dynamics: taking aim at a moving target
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dynamic instability of microtubule growth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microtubule-associated proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Wild-type p53 negatively regulates the expression of a microtubule-associated protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antimitotic natural products and their interactions with tubulin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of vinorelbine in patients with androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hand-foot syndrome following prolonged infusion of high doses of vinorelbine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Promotion of microtubule assembly in vitro by taxol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): a trial of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel: standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of weekly paclitaxel in advanced lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel administered on a weekly basis for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coping with toxicities of docetaxel (Taxotere)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glutamine treatment of paclitaxel-induced myalgias and arthralgias
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intestinal side-effects of docetaxel/vinorelbine combination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal toxicity associated with weekly docetaxel treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic properties of estramustine unrelated to alkylating and steroid constituents.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical and pharmacologic trial of intravenous estramustine phosphate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of tubulin at 6.5 A and location of the taxol-binding site.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of P-glycoprotein in dolastatin 10 resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of the dolastatin analogue, LU103793, in malignant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor activity of cryptophycins: effect of infusion time and combination studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Membrane-Mediated Drug Resistance and Phenotypic Reversion to Normal Growth Behavior of Chinese Hamster Cells 2
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multidrug resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transport function and substrate specificity of multidrug resistance protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Function, evolution and structure of multidrug resistance protein (MRP).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptional regulation of MDR genes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of the Taxol Binding Site on the Microtubule
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inactivation of Bcl-2 by phosphorylation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2803%2921003-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0921-4410(03)21003-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
PubMed publication ID
15338740
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15338740
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15338740%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit